Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis.

导出 OA

翻译打印收藏纠错

第一作者： Yufeng,Sun

第一单位： Department of Pathology, Medical School of Nantong University, Nantong, China.

作者： Yufeng,Sun ^[1] ; Wenchao,Li ^[2] ; Shiqi,Shen ^[3] ; Xuejing,Yang ^[4] ; Bing,Lu ^[1] ; Xiaojing,Zhang ^[5] ; Peng,Lu ^[6] ; Yi,Shen ^[6] ; Juling,Ji ^[1]

作者单位： Department of Pathology, Medical School of Nantong University, Nantong, China. ^[1] Basic Medical Research Centre in Medical College of Nantong University, Nantong, China. ^[2] Department of Epidemiology and Medical Statistics, Public Health School of Nantong University, Nantong, China. ^[3] Department of Biostatistics, Public Health School of Shandong University, Jinan, China. ^[4] Medical School of Nantong University, Nantong, China. ^[5] Department of Clinical Biobank, Affiliated Hospital of Nantong University, Nantong, China. ^[6] Department of Epidemiology and Medical Statistics, Public Health School of Nantong University, Nantong, China. sunny@ntu.edu.cn. ^[7] Department of Pathology, Medical School of Nantong University, Nantong, China. jijuling@ntu.edu.cn. ^[8]

关键词 Alanine-glyoxylate and serine-pyruvate aminotransferase Diagnostic marker Hepatocellular carcinoma Prognostic marker Systematic review